Brimonidine Tartrate
Showing 1 - 25 of 252
Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,
Not yet recruiting
- Allergic Conjunctivitis
- Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
- +3 more
-
Phoenix, Arizona
- +2 more
Nov 9, 2022
Seasonal Allergic Conjunctivitis Trial in Andover, Memphis (Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic
Not yet recruiting
- Seasonal Allergic Conjunctivitis
- Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
- +3 more
-
Andover, Massachusetts
- +1 more
Nov 9, 2022
Ocular Redness Trial in United States (Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation, Lumify®
Not yet recruiting
- Ocular Redness
- Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation
- Lumify® (brimonidine tartrate ophthalmic solution 0.025%)
-
Colorado Springs, Colorado
- +5 more
Apr 29, 2022
Presbyopia Trial in Memphis (BRIMOCHOL™ PF, Carbachol PF, Brimonidine tartrate)
Recruiting
- Presbyopia
- BRIMOCHOL™ PF
- +2 more
-
Memphis, TennesseeTotal Eye Care, PA
Apr 25, 2022
Glaucoma, Glaucoma, Open-Angle, Glaucoma; Drugs Trial in New Orleans (brimonidine tartrate ophthalmic solution 0.025%, sterile
Not yet recruiting
- Glaucoma
- +5 more
- brimonidine tartrate ophthalmic solution 0.025%
- sterile balanced saline solution
-
New Orleans, LouisianaTulane University Medical Center
Apr 4, 2022
Pterygium, Subconjunctival Hemorrhage Trial (Brimonidine Tartrate 0.15% Oph Soln, Brimonidine Tartrate 0.025% Oph Soln)
Not yet recruiting
- Pterygium
- Subconjunctival Hemorrhage
- Brimonidine Tartrate 0.15% Oph Soln
- Brimonidine Tartrate 0.025% Oph Soln
- (no location specified)
Dec 20, 2020
Glaucoma, Primary Open Angle, Ocular Blood Flow, Optical Coherence Tomography Angiography Trial in Fayoum (Brimonidine tartrate
Completed
- Glaucoma, Primary Open Angle
- +2 more
- Brimonidine tartrate 0.2% ophthalmic solution
-
Fayoum, EgyptFayoum University Hospitals
Jul 23, 2022
Presbyopia Trial in Mexico City (Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac, Pilocarpine
Recruiting
- Presbyopia
- Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac
- +2 more
-
Mexico City, MexicoOptall Vision
Aug 14, 2021
Eyelid Droop Trial in Miami (Brimonidine tartrate ophthalmic solution 0.025%, Sterile balanced saline solution)
Completed
- Eyelid Droop
- Brimonidine tartrate ophthalmic solution 0.025%
- Sterile balanced saline solution
-
Miami, FloridaBascom Palmer Eye Institute
Jun 7, 2021
Erythema, Rosacea Trial in United States (CD07805/47 gel 0.5%/CD07805/47 Vehicle, azelaic acid gel 15%)
Completed
- Erythema
- Rosacea
- CD07805/47 gel 0.5%/CD07805/47 Vehicle
- azelaic acid gel 15%
-
Evansville, Indiana
- +3 more
Jul 28, 2022
Rosacea, Erythema Trial in Germany, Sweden, United Kingdom (Brimonidine tartrate was applied cutaneously once daily for 8 days.,
Completed
- Rosacea
- Erythema
- Brimonidine tartrate was applied cutaneously once daily for 8 days.
- Brimonidine tartrate vehicle was applied cutaneously once daily for 8 days.
-
Berlin, Germany
- +13 more
Aug 23, 2021
Erythematous Rosacea Trial in Broomall (0.18% COL-118 facial gel (1.8 mg brimonidine), 0.2% brimonidine ophthalmic solution (0.1
Completed
- Erythematous Rosacea
- 0.18% COL-118 facial gel (1.8 mg brimonidine)
- +3 more
-
Broomall, PennsylvaniaKGL, Inc.
Feb 16, 2021
Subconjunctival Hemorrhage, Cataract Surgery Trial in Brampton (Brimonidine Tartrate 0.15% Oph Soln)
Completed
- Subconjunctival Hemorrhage
- Cataract Surgery
- Brimonidine Tartrate 0.15% Oph Soln
-
Brampton, Ontario, CanadaUptown Eye Speicialists
Nov 16, 2020
Open Angle Glaucoma, Ocular Hypertension Trial in United States (Brimonidine Tartrate Ophthalmic Suspension, Brimonidine
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Brimonidine Tartrate Ophthalmic Suspension
- Brimonidine Tartrate Ophthalmic Solution
-
Chandler, Arizona
- +46 more
Jan 27, 2022
Glaucoma; Drugs, Normal Tension Glaucoma, Primary Open-angle Glaucoma Trial in Philadelphia (Timolol Maleate, Brimonidine
Completed
- Glaucoma; Drugs
- +2 more
- Timolol Maleate
- Brimonidine Tartrate
-
Philadelphia, PennsylvaniaGlaucoma Research Center - Wills Eye Hospital
Dec 4, 2020
Glaucoma, Ocular Hypertensive Trial in Seongnam (Brimonidine Tartrate 1.5mg)
Active, not recruiting
- Glaucoma
- Ocular Hypertensive
- Brimonidine Tartrate 1.5mg
-
Seongnam, Bundang-gu, Korea, Republic ofCHA University Bundang Medical Center
Nov 23, 2020
Hyperemia Trial in Memphis (Brimonidine Tartrate, Vehicle, Sodium Fluorescein)
Completed
- Hyperemia
- Brimonidine Tartrate
- +3 more
-
Memphis, TennesseeBausch & Lomb Incorporated
Oct 22, 2019
Flushing, Alcohol-Related Disorders, Aldehyde Dehydrogenase Deficiency Trial in San Francisco (Brimonidine Tartrate, Placebo
Completed
- Flushing
- +2 more
- Brimonidine Tartrate
- Placebo Vehicle Gel
-
San Francisco, CaliforniaUC, San Francisco
Apr 30, 2020
Preferences & Treatment Satisfaction Drivers in Rosacea Patients
Completed
- Rosacea
- Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251)
- +6 more
-
Boston, Massachusetts(unnamed)
Mar 30, 2020
Posterior Capsule Opacification, Ocular Hypertension Trial in Patra (Brinzolamide/Brimonidine FC, Brimonidine 0.2%, Artificial
Completed
- Posterior Capsule Opacification
- Ocular Hypertension
- Brinzolamide/Brimonidine FC
- +2 more
-
Patra, Achaia, GreeceUniversity Hospital of Patras
Jun 23, 2019
Hand-foot Syndrome Trial in Düsseldorf (Brimonidine Tartrate)
Terminated
- Hand-foot Syndrome
- Brimonidine Tartrate
-
Düsseldorf, GermanyUniversitätsklinikum Düsseldorf, Klinik für Dermatologie
Jan 7, 2019
Glaucoma Trial in Indianapolis (fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution, fixed
Completed
- Glaucoma
- fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution
- fixed combination of dorzolamide hydrochloride timolol maleate ophthalmic solution
-
Indianapolis, Indiana(unnamed)
Apr 10, 2019